Factors associated with tuberculin skin test reactivity among HIV-infected people in Bangkok

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 34, Issue 4, 2003, Pages 804-809

  Hiransuthikul, Narin ^a   Hanvanich, Mattana ^a   Dore, Gregory J ^b   Mokkhawes, Thawatchai ^c   Li, Yueming ^b   Perriens, Jos ^d   Kaldor, John M ^b  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

^d UNAIDS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; ISONIAZID; RIFAMPICIN; TUBERCULIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BISEXUALITY; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HETEROSEXUALITY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; PREVALENCE; PROSTITUTION; PROTEIN DETERMINATION; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; THAILAND; TUBERCULIN TEST; TUBERCULOSIS;

EID: 1842785175     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Allen S, Batungwanayo J, Kerlikowske K, et al. Two-year incidence of tuberculosis in cohorts of HIV-infected and uninfected urban Rwandan women. Am Rev Respir Dis 1992; 146: 1439-44.
2. nd Review of the National Tuberculosis Programme in Thailand, conducted by a Joint Team of Thailand Ministry of Public Health and WHO, 10-23 July 1999. WHO/CDS/TB/99. 273, 1999. 1999.
3. st October, 2000.
4. Antonucci G, Girardi E, Raviglione MC, Ippolito G. Risk factors for tuberculosis in HIV-infected persons: A prospective cohort study. JAMA 1995; 274: 143-8.
5. Arnadottir T, Rieder HL, Trebucq A, Waaler HT. Guidelines for conducting tuberculin skin test surveys in high prevalence countries. Tuberc Lung Dis 1996; 77 (suppl): 1-19.
6. Braun MM, Badi N, Ryder RW, et al. A retrospective cohort study of the risk of tuberculosis among women of child-bearing age with HIV infection in Zaire. Am Rev Respir Dis 1991; 143: 501-4.
7. Centers for Disease Control. Prevention and treatment of tuberculosis among patients infected with human immunodefficiency virus: principles of therapy and revised recommendations. Morbid Mortal Weekly Rep 1998; 47 (RR-20): 36-41.
8. Daley CL, Small PM, Schecter GP, et al. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphism. N Engl J Med 1992; 326: 231-5.
9. Dolin PJ, Raviglione MC, Kochi A. Global tuberculosis incidence and mortality during 1990-2000. Bull WHO 1994, 72: 213-20.
10. Garcia-Garcia ML, Valdespino-Gomez JL, Garcia-Sanchoc, et al. Underestimation of Mycobacterium tuberculosis infection in HIV-infected subjects using reactivity to tuberculin and anergy panel. Int J Epidemiol 2000; 29: 369-75.
11. Giradi E, Reviglione MC, Antonucci G, Godfrey-Faussett P, Ippoloti G. Impact of the HIV epidemiology on the spread of other diseases: the case of tuberculosis. AIDS 2000; 14 (suppl 3): 547-56.
12. Guelar A, Gatell JM, Verdejo J, et al. A prospective study of the risk of tuberculosis among HIV-infected patients. AIDS 1993; 7: 1345-9.
13. Johnson MP, Coberty JS, Clermont HC, et al. Tuberculin skin test reactivity among adults infected with human immuuodeficiency virus. J Infect Dis 1992; 166: 194-8.
14. Markowitz N, Hansen NL, Wilcosky TC, et al. Tuberculin and anergy testing in HIV- seropositive and HIV-seronegative persons. Ann Intern Med 1993; 119: 185-93.
15. Moreno S, Baraia-Etxaburu J, Bouza E, et al. Risk for developing tuberculosis among anergic patients infected with HIV. Ann Intern Med 1993; 119: 194-8.
16. Narain JP, Raviglione MC, Kochi A. HIV-associated tuberculosis in developing countries: epidemiology and strategies for prevention. Tuberc Lung Dis 1992; 78: 311-21.
17. Pape JW, Jean SS, Ho JL, Hafner A, Johnson WD. Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet 1993; 342: 268-72.
18. Payanandana V, Bamrungtrakul T, Sriyabhaya K. Report of an internal evaluation of the national tuberculosis programme 1993. Tuberculosis Division, Department of Communicable Disease Control, Ministry of Public Health, Thailand. 1993.
19. Payanandana V, Kladphuang B, Talkitkul N, Tornec S. Information in preparation for an external review of The National Tuberculosis Programme, Thailand 1995. Tuberculosis Division, Department of Communicable Disease Control, Ministry of Public Health, Thailand. 1995.
20. Selwyn PA, Hartel D, Lewis VA, et al. High risk of active tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989; 320: 545-50.
21. Selwyn PA, Sckell BM, Alcabas P, Rriedland GH, Klein RS, Schoenbaum EF. High risk of active tuberculosis in HIV infected drug users with cutaneous anergy. JAMA 1992; 268: 504-9.
22. Styblo K. The impact of HIV infection on the global epidemiology of tuberculosis. Bull Int Union Tuberc Lung Dis 1991; 66: 27-36.
23. Suwanagool S, Chuenarom V, Pechthanon L, et al. A comparative study of tuberculin skin test reactivity between asymptomatic HIV-1 seropositive subjects and healthy volunteers. Asian Pac J Allergy Immunol 1995; 13: 139-44.
24. Wadhawan D, Hira SK, Mwansa N, Tembo G, Perrine P. Isoniazid prophylaxis among patients with HIV-1 infection [Abstract TuB 0536]. Amsterdam: VIII International Conference on AIDS, and III Sexually Transmitted Disease World Congress, July 1992.
25. Wilkinson D, Squire SB, Garner P. Effect of preventive treatment for tuberculosis in adults infected with HIV: systematic review of randomized placebo controlled trials. Br Med J 1998; 317: 625-9.
26. World Health Organization. Global programme on AIDS and tuberculosis programme. Wkly Epidemiol Rec 1989; 64: 125-31.
27. Yanai H, Uthaivoravit W, Panich V, et al. Rapid increase in HIV-related tuberculosis, Chiang Rai, Thailand, 1990-1994. AIDS 1996, 10: 527-31.